** = Publikationen gelistet in SCI/SSCI/Pubmed
** Prunea, DM; Bachl, E; Herold, L; Kanoun, Schnur, SS; Pätzold, S; Altmanninger-Sock, S; Sommer, GA; Glantschnig, T; Kolesnik, E; Wallner, M; Ablasser, K; Bugger, H; Buschmann, E; Praschk, A; Fruhwald, FM; Schmidt, A; von, Lewinski, D; Toth, GG
Impact of the Timing of Mechanical Circulatory Support on the Outcomes in Myocardial Infarction-Related Cardiogenic Shock: Subanalysis of the PREPARE CS Registry.
J Clin Med. 2024; 13(6): 1552
Doi: 10.3390/jcm13061552
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** von, Lewinski, D; Herold, L; Bachl, E; Bugger, H; Glantschnig, T; Kolesnik, E; Verheyen, N; Benedikt, M; Wallner, M; von, Lewinski, F; Schmidt, A; Harb, S; Ablasser, K; Sacherer, M; Scherr, D; Manninger-Wünscher, M; Pätzold, S; Gollmer, J; Zirlik, A; Toth, GG
Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort.
J Clin Med. 2023; 12(22):
Doi: 10.3390/jcm12226988
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Haudum, CW; Kolesnik, E; Colantonio, C; Mursic, I; Url-Michitsch, M; Tomaschitz, A; Glantschnig, T; Hutz, B; Lind, A; Schweighofer, N; Reiter, C; Ablasser, K; Wallner, M; Tripolt, NJ; Pieske-Kraigher, E; Madl, T; Springer, A; Seidel, G; Wedrich, A; Zirlik, A; Krahn, T; Stauber, R; Pieske, B; Pieber, TR; Verheyen, N; Obermayer-Pietsch, B; Schmidt, A
Cohort profile: 'Biomarkers of Personalised Medicine' (BioPersMed): a single-centre prospective observational cohort study in Graz/Austria to evaluate novel biomarkers in cardiovascular and metabolic diseases.
BMJ Open. 2022; 12(4):e058890
Doi: 10.1136/bmjopen-2021-058890
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Posch, F; Niedrist, T; Glantschnig, T; Firla, S; Moik, F; Kolesnik, E; Wallner, M; Verheyen, N; Jost, PJ; Zirlik, A; Pichler, M; Balic, M; Rainer, PP
Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer.
Front Cardiovasc Med. 2022; 9: 933428
Doi: 10.3389/fcvm.2022.933428
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Glantschnig, T; Koppelstatter, C; Zweiker, D; Kolesnik, E; Niederl, E; Kraler, E; Stoff, I; Zweiker, R; Weber, T; Horn, S; Weiss, T; Wang, W; Beaney, T; Poulter, NR; Perl, S
May Measurement Month 2018-2019: an analysis of blood pressure screening results from Austria( )
EUR HEART J SUPPL. 2022; 24(SUPP F): F6-F8.
Doi: 10.1093/eurheartjsupp/suac038
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Herold, L; Toth-Gayor, G; Fruhwald, F; Patzold, S; Altmanninger-Sock, S; Harb, S; Schmidt, A; Buschmann, E; Bugger, H; Ablasser, K; Glantschnig, T; Bisping, E; Stoffel, C; Knopper, S; Weixler, R; Muckenauer, W; Zweiker, R; Gasser, R; Zirlik, A; von Lewinski, D
Influence of OFF-hours admission on outcome of CS-patients at a high-volume cardiology centre
WIEN KLIN WOCHENSCHR. Abstracts der Österreichische Kardiologische Gesellschaft Jahrestagung 2022. 2022; 134(SUPPL 2):190-191.-Österreichische Kardiologische Gesellschaft Jahrestagung 2022; MAI 25-28, 2022; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Glantschnig, T; Theiler-Schwetz, V; Pilz, S; Obermayer-Pietsch, B; Ablasser, K; Kolesnik, E; Patzold, S; Pieber, T; Zirlik, A; Bugger, H
NSTEMI as initial manifestation of pheochromocytoma induced multi organ failure.
WIEN KLIN WOCHENSCHR. 2020; 132: S197-S197.
[Poster]
Web of Science
** Ablasser, K; Verheyen, N; Glantschnig, T; Agnetti, G; Rainer, PP
Unfolding Cardiac Amyloidosis -From Pathophysiology to Cure.
Curr Med Chem. 2019; 26(16):2865-2878
Doi: 10.2174/0929867325666180104153338
Web of Science
PubMed
FullText
FullText_MUG
** Glantschnig, T; Posch, F; Firla, S; Moik, F; Ablasser, K; Binder, JS; Stoschitzky, G; Wallner, M; Von Lewinski, D; Stoger, H; Zirlik, A; Pichler, M; Rainer, PP
Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
WIEN KLIN WOCHENSCHR. 2019; 131: 292-293.
[Poster]
Web of Science
** Posch, F; Glantschnig, T; Firla, S; Smolle, M; Balic, M; Moik, F; Stoeger, H; Zirlik, A; Pichler, M; Rainer, P
Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
EUR HEART J. 2019; 40: 3844-3844.-ESC Congress / World Congress of Cardiology; AUG 31-SEP 04, 2019; Paris, FRANCE.
[Poster]
Web of Science
** Glöcklhofer, CR; Steinfurt, J; Franke, G; Hoppmann, A; Glantschnig, T; Perez-Feliz, S; Alter, S; Fischer, J; Brunner, M; Rainer, PP; Köttgen, A; Bode, C; Odening, KE
A novel LMNA nonsense mutation causes two distinct phenotypes of cardiomyopathy with high risk of sudden cardiac death in a large five-generation family.
Europace. 2018; 20(12):2003-2013
Doi: 10.1093/europace/euy127
Web of Science
PubMed
FullText
FullText_MUG
** Gossler, J; Glantschnig, T; Zweiker, D; Praschk, A; Toth-Gayor, G; Zweiker, R
Influence of ticagrelor on cardiovascular risk factors in patients after PCI
WIEN KLIN WOCHENSCHR. 2018; 130: 101-102.
[Poster]
Web of Science
** Glantschnig, T; Ablasser, K; Verheyen, N; von Lewinski, D; Rainer, PP
What may happen when you are expecting - a case of peripartum
cardiomyopathy
Eur J Heart Failure. 2018; 20(S1):358-358.-Heart Failure Association ESC; MAY 26-29, 2018; Vienna, AUSTRIA.
[Poster]
Web of Science